---
title: Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification
  of Alzheimer's disease and 4R-tauopathies
date: '2024-09-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39263969/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240912200457&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Recent advances in biomarker research have improved the
  diagnosis and monitoring of Alzheimer''s disease (AD), but in vivo biomarker-based
  workflows to assess 4R-tauopathy (4RT) patients are currently missing. We suggest
  a novel biomarker-based algorithm to characterize AD and ...'
disable_comments: true
---
INTRODUCTION: Recent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer's disease (AD), but in vivo biomarker-based workflows to assess 4R-tauopathy (4RT) patients are currently missing. We suggest a novel biomarker-based algorithm to characterize AD and ...